FATE Forecast



Bearish<—>Bullish



80% Confidence




Bullish Case: Innovation in iPSC-derived therapies and potential approvals could drive substantial growth, buoyed by improving investor sentiment.




Bearish Case: Regulatory hurdles and recent financial instability pose significant risks. High implied volatility underscores market's uncertainty.




Potential Outcomes:
  • Drug approval (30%): Price doubles.
  • Regulatory setback (25%): Price halves.
  • Neutral progress (45%): Minor fluctuations.



April 26, 2025


Fate Therapeutics Forecast

FATE        Fate Therapeutics











Correlated Assets

Assets that tend to move strongly with FATE



CAL Forecast + Options Trading Strategies   CAL  Caleres (0.91)


ADNT Forecast + Options Trading Strategies   ADNT  Adient (0.91)


ASH Forecast + Options Trading Strategies   ASH  Ashland (0.91)


CRON Forecast + Options Trading Strategies   CRON  Cronos (0.9)


ODP Forecast + Options Trading Strategies   ODP  ODP (0.89)



Uncorrelated Assets

Assets with little price relationship to FATE



FLR Forecast + Options Trading Strategies   FLR  Fluor (0.01)


DXC Forecast + Options Trading Strategies   DXC  DXC Technology (0.01)


DPZ Forecast + Options Trading Strategies   DPZ  Dominos Pizza (-0.01)


CVX Forecast + Options Trading Strategies   CVX  Chevron (0.02)


EA Forecast + Options Trading Strategies   EA  Electronic Arts (0.02)



Anticorrelated Assets

Assets that tend to move strongly against FATE



USAU Forecast + Options Trading Strategies   USAU  U.S. Gold (-0.83)


BK Forecast + Options Trading Strategies   BK  Bank Of New York Mellon (-0.83)


LNG Forecast + Options Trading Strategies   LNG  Cheniere Energy (-0.84)


RL Forecast + Options Trading Strategies   RL  Ralph Lauren (-0.84)


TPR Forecast + Options Trading Strategies   TPR  Tapestry (-0.88)









Become a more profitable investor with AI optimized trading strategies






×

Chat with FATE


 Ask any question about FATE!